Investors

NAHC Investor Community

The Nordic-American Healthcare Conference offers US Institutional generalist and specialist healthcare investors the opportunity to connect with compelling healthcare and life science companies from the US and the Nordics, all in a personal, knowledgeable, and highly informative environment. Over two days, investors attend company presentations and on-site meetings with our NAHC companies and hear from internationally-regarded keynote speakers and panelists.

Many investors return to the NAHC every year for:

  • Efficient 1x1 and Group Meeting Opportunities   The NAHC brings together 25 high-value companies and offers investors the opportunity to meet with leading large- and mid-cap public and private IPO-ready US and Nordic life science companies, presented primarily by company CEOs and senior management.

  • Personal and Small-Format Forum – The NAHC provides a personal format forum open to investors and company-specific corporate development and management teams.

  • High Quality Presentations – The NAHC presents companies with demonstrated technologies, substantial advancements, upcoming inflection points, and attractive investor basis - making them highly appealing investment opportunities. Companies selected with DNB Carnegie | Back Bay criteria, expertise, research coverage and growth potential.

  • Content-Rich Program for Investors and Companies Alike The NAHC offers a specialized, high-level program reflecting the specific issues that investors and companies consider as they contemplate further investment in the sectors and ensures presenting companies are relevant and positioned for the investor base

 

NAHC 2026 Registered Invstors Included:

Ally Bridge Group
Alumni Capital Management
Artisan Partners
Atlantic Family Office
Black Rock
Borex Capital
Brookline Capital Markets
Camford Capital
CBC Group/C-Bridge Capital
Chemical Angel Network
Chicago Booth Angels
Clearline Capital
Critical Value Asset Management
CVC
DR Capital Management
Esousa Holdings
F.B. Asset. Management
GEM Group
Global Value Investment Corporation
Health Innovation Capital
Hound Partners
Ingenious Global Venture Partners
Innovestor
Joseph Gunnar/Buttonwood Group Advisors LLC
Kendall Capital Partners
Li Family Office
Longstate Investments
Lord Abbett & Co. LLC
M3 Capital Partners
Max Ventures
Meditek Capital AS
Morgan Capital Group
NGN Capital LLC
Oberland Capital
Omers Life Sciences
OrbiMed Advisors
Petrichor
Phalanx Investment Partners
Pharmakon Advisors
Prevail Partners LLC
Royalty Pharma
Serrado Capital
Sternberg Investments
Stone Capital Partners
TWC
Vector Capital
William Blair
Yorkville Advisors Global, LP


NAHC 2026 Registered Investors to Date:

Advent Capital Management
Ally Bridge Group
American Century Investment Management
Artisan Partners
Atlantic Family Office
Axiom Investors
Barings
Black Diamond Advisors
BlackRock
BoJian Capital
Brighton Capital
CBC Group
Chemical Angel Network
Clearline Capital
Craft Capital Management
Capital Royalty Group
Critical Value Asset Management
C10 Labs
Erez Capital
ExSight Ventures
F.B. Asset Management
FoxHill Asset Management
Gainbridge Capital
GCF Family Office
Global Corporate Finance
Global Emerging Markets
Global Investment Corporation
Global Value Investors
Harvard Investors Group
Health Innovation Capital
HealthCare Royalty
HI Investors Capital
Innovatus Capital Partners
Invesco Advisers
Joseph Gunnar & Company
Kuberan Capital Management
Lazard Asset Management
Lord, Abbett & Co
Oaktree Capital Management
OMERS Life Sciences
Nobel Equity
Petrichor Healthcare Capital Management
Pharmakon Advisors
Prevail Partners
Royalty Pharma Management
RTW Investments
Sector Asset Management 
Serrado Capital
Stonebridge Capital Management
T&W Medical 
TimesSquare Capital Management
TransAtlantic LifeSciences Ventures
Trinity Capital 
Vector Capital Associates
William Blair & Company
Yorkville Global